High Court Won't Hear Apotex's Risperdal Appeal
Apotex Inc. has lost its bid to have the nation's highest court revive its counterclaims of noninfringement in connection with a patent fight over Johnson & Johnson subsidiary Janssen Pharmaceutica NV's...To view the full article, register now.
Already a subscriber? Click here to view full article